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Abstract Antimicrobial peptides (AMPs) are essential
components of innate immunity in a range of species
fromDrosophila to humans and are generally thought to
act by disrupting the membrane integrity of microbes. In
order to discover novel AMPs in the chicken, we have
implemented a bioinformatic approach that involves the
clustering of more than 420,000 chicken expressed
sequence tags (ESTs). Similarity searching of proteins—
predicted to be encoded by these EST clusters—for
homology to known AMPs has resulted in the in silico
identification of full-length sequences for seven novel
gallinacins (Gal-4 to Gal-10), a novel cathelicidin and a
novel liver-expressed antimicrobial peptide 2 (LEAP-2) in
the chicken. Differential gene expression of these novel
genes has been demonstrated across a panel of chicken
tissues. An evolutionary analysis of the gallinacin family
has detected sites—primarily in the mature AMP—that are
under positive selection in these molecules. The functional
implications of these results are discussed.
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Introduction
Antimicrobial peptides (AMPs), essential components of
innate host defence in species as diverse as plants, flies
and mammals are generally thought to act by disrupting
the membrane integrity of microbes (Kagan et al. 1990;
Satchell et al. 2003). In an age when antibiotic resistance
is an increasing problem, these peptides are of interest as
potential novel pharmaceutical agents. In vertebrates, there
are two major families of AMPs: defensins and cathe-
licidins. In mammals, α-defensins and β-defensins are two
structurally distinct cationic, cysteine-rich AMPs, which
differ in size and in the spacing of a six-cysteine structural
motif (Liu et al. 1997). α-defensins are unique to
mammals, but β-defensins are much more widely
distributed and, in the chicken, four β-defensins, known
as gallinacins, have been described to date (Evans et al.
1994; Harwig et al. 1994; Zhao et al. 2001). Homologous
peptides have also been described in the turkey (Evans et
al. 1994; Zhao et al. 2001). Gal-1, Gal-1α and Gal-2 were
isolated from chicken heterophils, while Gal-3 was shown
to be constitutively expressed in the epithelia of a range of
tissues and to be inducible in the trachea following
infection (Zhao et al. 2001). Gallinacins exhibit variable
activity against a number of Gram-positive and Gram-
negative bacteria, and Gal-1 and Gal-1α are active against
the yeast Candida albicans (Evans et al. 1995; Harmon
1998).
Cathelicidins are a family of highly diverse AMPs but
are all encoded by prepropeptides containing highly
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conserved cathelin domains. To date, cathelicidins have
only been described in mammals, including humans,
monkeys, horses, cattle, sheep, goats, pigs, rabbits, mice
and guinea pig (for review, see Ramanathan et al. 2002).
Each species has variable numbers of cathelicidin genes;
artiodactyls in particular have high copy numbers (Scocchi
et al. 1997), whereas humans and mice have only one gene
copy each (Agerberth et al. 1995; Cowland et al. 1995;
Gallo et al. 1997; Larrick et al. 1995). Neutrophils are a
particularly rich source of cathelicidins in a variety of
species. In humans, cathelicidins have also been found to
be expressed in several other tissues, including the testis
(Agerberth et al. 1995; Malm et al. 2000), squamous
epithelia (Frohm Nilsson et al. 1999; Nizet et al. 2001),
airway epithelia (Bals et al. 1998), sweat glands
(Murakami et al. 2002b), salivary glands (Murakami et
al. 2002a) and colon (Hase et al. 2002). Cathelicidins have
a wide spectrum of antimicrobial activity and have been
shown to be active against Gram-negative and Gram-
positive bacteria (Travis et al. 2000), fungi (Shin et al.
2000) and enveloped viruses (Tamamura et al. 1995).
Activity against a particular microbe depends on the type
of mature peptide and the species from which it originates.
In this study, we describe a bioinformatics approach to
the identification of novel AMPs in the chicken. This
method involves homology searching of clustered chicken
expressed sequences tags (ESTs) by BLAST (Altschul et
al. 1997) and by the more sensitive hidden Markov model
(HMM) profile searching (Eddy 1998). Our approach has
identified eight novel antimicrobial peptides, seven
gallinacins and one cathelicidin in the chicken. We show
that all these peptides as well as liver-expressed antimi-
crobial peptide 2 (LEAP-2)—an AMP we have previously
identified in chicken (Lynn et al. 2003)—are expressed at
the mRNA level in a panel of chicken tissues. Further-
more, an evolutionary analysis of the gallinacin family has
provided evidence that certain amino acid sites in the
active peptide are subject to positive selection.
Materials and methods
From the dbEST Web site (http://www.ncbi.nlm.nih.gov/dbEST/),
422,426 chicken ESTs were downloaded. Prior to the clustering
step, repeat sequences in the ESTs were masked using RepeatMas-
ker (Smit and Green, unpublished), and contaminant sequences were
removed using SeqClean (http://www.tigr.org/tdb/tgi/software/) to
minimize false clustering due to spurious EST similarity.
The ESTs were then clustered using The Institute for Genomic
Research Gene Indices clustering tools (TGICL) (Pertea et al. 2003)
(available from http://www.tigr.org/tdb/tgi/software/). ESTs were
clustered if they shared more than 30 bp of at least 95% identity. The
clustered contig sequences are available at http://www.binf.org/
immunogenetics/contigs.fa.
The sequences for each cluster were post-processed with
ESTScan (Iseli et al. 1999). ESTScan detects and reconstructs
potential coding regions in ESTs, using a novel HMM method that
can automatically correct for frame-shift errors. From the coding
regions, the predicted protein can be determined (available at http://
www.binf.org/immunogenetics/estscanpredictions.fa). A database of
known AMPs, as identified by an SRS search (http://srs.ebi.ac.uk/)
of the Swissprot-Trembl protein database was constructed and is
available at http://ercbinfo1.ucd.ie/APPDb/. All AMPs from this
database were searched against the clustered EST contigs and the
database of proteins predicted by ESTScan from the EST clusters
using the BLAST programs, with an E-value cut-off of 0.001
(Altschul et al. 1997). Molecular weight and net charge for the
complete chicken proteins were predicted using the ProtParam tool
(http://www.expasy.org/tools/protparam.html).
To search for novel antimicrobial proteins that could have been
missed by BLAST, we constructed HMMs for a number of AMP
families. All the sequences annotated as either α-defensins,
cathelicidins or hepcidins in the Pfam database (Bateman et al.
2002)—a manually curated and annotated collection of protein
families (http://www.sanger.ac.uk/Software/Pfam)—were extracted.
The gallinacin family is not represented in the Pfam database, so all
known gallinacin sequences were extracted from the National
Center for Biotechnology Information GenPept protein database.
These sequences included Gal-1 (P46156), Gal-1α (Q9DG59), Gal-
2 (P46158), Gal-3 (Q9DG58), turkey heterophil peptide-1 (THP1)
(P80391), THP2 (P80392) and turkey β-defensin (TBD) (Q9DG57).
To create an HMM profile for each family, all constituent sequences
of AMPs were aligned using the T-Coffee program (Notredame et al.
2000), and these alignments were used as input for the HMMER,
version 2.1.1, suite of programs (Eddy 1998) (http://hmmer.wustl.
edu/). The HMM for each family was constructed using the
Table 1 PCR primer sequences and predicted product lengths
Target mRNAa 5′ Primer 3′ Primer Product
size (bp)
Gal-1 5′-GAAATGCTCAAGATTTCACCTCTG-3′ 5′-CCTTTATTCAGCAGAGAAAAGCAG-3′ 231
Gal-2 5′-GCATAAACACTTCATGAGTCCATC-3′ 5′-GAAGAAAGGCAGTGCAGAAGATA-3′ 166
Gal-3 5′-CCTTCTTCCTCTTGTTTCTCCAG-3′ 5′-ATCAACCTCATATGCTCTTCCAC-3′ 158
Gal-4 5′-GATCCTTTACCTGCTGCTGTCT-3′ 5′-TCCTCACACAGCAAGATTTTAGTC-3′ 185
Gal-5 5′-GATCCTTTACCTGCTGCTGTCT-3′ 5′-AGCAAGAGCCTATTCCATTGTTAC-3′ 176
Gal-6 5′-ATGAGAATCCTTTTCTTCCTTGTTGC-3′ 5′-TTAGGAGCTAGGTGCCCATTTGCAGC-3′ 201
Gal-7 5′-ATCGTGCTCCTCTTTGTGGCAGTTCA-3′ 5′-CTACAACCATCTACAGCAAGAATACT-3′ 171
Gal-8 5′-CTGTTCTCCTCTTCCTCTTCCAG-3′ 5′-AATCTTGGCACAGCAGTTTAACA-3′ 170
Gal-9 5′-ATGCAGATCCTGCCTCTCCTCTTTGCT-3′ 5′-TCAGGAATACCATCGGCTCCGGCAGCAGAA-3′ 201
Gal-10 5′-ATGAGGAACCTTTGTTTCGTGT-3′ 5′-TCAGGTCTTGGTGGGAGTTGGTG-3′ 198
LEAP-2 5′-CACCATGCACTGTTTGAAAATTATGGCA-3′ 5′-TCACTCGGAGGCCGTTCTAAGGAA-3′ 235
Cathelicidin 5′-CACCATGCTGAGCTGCTGGGTGCTGCTG-3′ 5′-TCACTTCTTCTTGATCGCCCGGTA-3′ 451
β-actin 5′-GCGCTCGTTGTTGACA-3′ 5′-TCATCCCAGTTGGTGACA-3′ 206
aGal-Gallinacin, LEAP-2 liver-expressed antimicrobial peptide 2
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hmmbuild program, and hmmcalibrate was used to calibrate E-value
scores. The HMM profiles were then used to search against the
database of proteins predicted by ESTScan from the EST clusters
using the hmmsearch program.
Evolutionary analysis of the gallinacins
A multiple-sequence alignment of the gallinacin family of AMPs
(including the novel sequences and the homologous turkey
sequences) was constructed using the T-Coffee program (Notredame
et al. 2000). A neighbor-joining phylogenetic tree was inferred from
the protein alignment using MEGA, version 2.1, with the Poisson
corrected model implemented (Kumar et al. 2001). One thousand
bootstrap replicates were carried out to test the significance of each
node in the tree. To construct an alignment of the coding sequences,
the protein alignment was used as a template and a ‘copygaps’ Perl
script was used to align the DNA, maintaining the gaps that were
present in the protein alignment. Any columns in the DNA
alignment that had more than three gap characters were removed.
The topology of the neighbor-joining tree and the DNA alignment
were used as input to the CODEML and CODEMLSITES programs
from the PAML package, version 3.12 (Yang 1997), to test for
evidence of positive selection during the evolution of the
gallinacins.
The principle involved in such tests is to compare the rates of
synonymous (dS) and non-synonymous (amino acid changing: dN)
changes among the DNA sequences. If amino acid changes are
selectively neutral (i.e. mutations that are neither advantageous or
deleterious), they will be fixed at the same rate as synonymous
mutations and ω ratio (dN/dS)=1. ω values >1 are taken to indicate
that amino acid changes are accumulating at a faster rate than is
acceptable under a neutral mutation model. That is to say, the rate of
amino acid changes (dN) significantly exceeds the rate of
synonymous changes (dS) at the DNA level. The CODEML
program tests for variable selective pressures among lineages in
the phylogeny by looking for significant differences in ω ratios. To
test for variable selective pressures among phylogenetic lineages,
the one-ratio model, which assumes an equalω ratio for all branches
in the phylogeny, was compared to the free-ratios model, which
allows an independent ω ratio for each branch (Yang 1998; Yang
and Nielsen 1998). The result of this program is a log-likelihood
value for each model. To test which is the favoured model, the log-
likelihood values for each model are compared by a likelihood ratio
test (LRT). Twice the log-likelihood difference between the two
models is compared to a χ2 distribution with n−1 df, where n is the
number of branches of the phylogeny. If a significant P-value is
obtained, it can be concluded that the free-ratios model is the
favoured model, and branches on the phylogeny with ω values >1
are subject to positive selection.
Positive selection in amino acid sites
Another way of looking for positive selection is to look for
significant variability in ω ratios among amino acid sites in the
multiple-sequence alignment (Nielsen and Yang 1998). The
CODEMLSITES program determines whether any of six progres-
sively more complex models of evolution are significantly better at
explaining the observed variation in the dataset (Yang et al. 2000).
The first test compares the models M0 and M3. Model M0 is an
evolutionary model whereby all the amino acid sites have a singleω
value. This model is compared to M3, which classifies the amino
acid sites into one of three classes, with the proportion of sites
belonging to a particular class and the ω values for each class of site
estimated by CODEMLSITES from the data. M3 is a test of amino
acid sites subject to positive selection, as it allows for the presence
of sites with ω>1.
The second test compares the models M1 and M2. M1 is a model
of neutral evolution where amino acid sites can be conserved (ω=0)
or neutrally evolving (ω=1). Model M2 is a test of selection, as it
allows for the presence of sites where ω is a free parameter and as
such can have a value >1.
The final test, which compares the models M7 and M8, is the
most stringent test. M7 allows for sites with ω values that follow a
β distribution of values between ω= 0 and ω=1. Model M8 is the
same as M7 but allows for the presence of sites with ω>1, and
comparing these two models is a test of selection.
As with the test of positive selection among lineages, CODEML-
SITES estimates a log-likelihood value for each model. To test
which are the favoured models, the log-likelihood values for M0
versus M3, M1 versus M2 and M7 versus M8 were compared by
LRTs. Posterior Bayesian probabilities were calculated to determine
which amino sites belong to which site classes (Nielsen and Yang
1998). If significant variability is revealed, then those sites, which
have ω>1 and high posterior probabilities, are likely to be under
positive, diversifying selection.
Expression of AMPs in chicken tissue
One-day-old male chickens (Cobb 500 broiler) were purchased from
the Knocknagarm Hatchery, then housed in a floor pen in the
Biomedical Facility, University College Dublin, Belfield, Dublin,
Ireland. Environmental temperature was kept at a constant 25°C.
Animals were fed commercial coccidiostat-free starter/grower ration
and water ad lib. One bird was sacrificed at 3 weeks of age by
intravenous pentobarbitone sodium inoculation. The tissues were
quickly dissected, squeezed between Whatman filter paper to
remove excess blood, rinsed in saline and snap frozen in liquid
nitrogen. Tissues were stored at −80°C until processed further.
Following pulverisation of the tissues using a Mikro-Dismembrator
U (B. Braun Biotech International), total cellular RNA was purified
using the RNeasy Kit (Qiagen, West Sussex, UK) according to the
manufacturer’s recommendations. Spectrophometric analysis was
performed in order to assess the quantity and quality of total RNA.
Single-stranded cDNAwas synthesised from 1 μg RNA using oligo-
dT primer (Promega, Madison, Wis.) and Omniscript (Qiagen). The
AMP-specific cDNAs were amplified by PCR using Taq polymerase
(Qiagen) and primers designed internally from the coding sequence
of Gal-1 to Gal-10, LEAP-2, cathelicidin and β-actin. Thirty cycles
(94°C for 30 s, 55°C for 30 s and 72°C for 30 s) were used for
amplification. PCR products were separated by electrophoresis on
ethidium bromide-stained 2% agarose gels and visualised using
Eagle Eye (Stratagene, La Jolla, Calif.). A list of PCR primer
sequences and product lengths are shown in Table 1.
cDNA cloning
Positive tissues from the above expression panel were chosen as
source material for each specific gene. The cDNA was amplified as
described above but using Pfu DNA polymerase (Promega) and
gene-specific primers with CACC overhangs upstream of the start
codon, thus providing the complementary sequence necessary for
directional cloning. The amplified cDNA was purified (GenElute
PCR Clean-up Kit, Sigma, St. Louis, Mo.), and ligated into the
pcDNA 3.1 cloning vector (Invitrogen, Groningen, The Nether-
lands). Cloned plasmids were sequenced (Advanced Biotechnology
Centre, London, UK), using vector-specific primers and compared
to the EST consensus sequence.
Results
In the absence of complete genome sequence, ESTs are a
rich source of novel sequence information. By definition,
ESTs are short, error-prone sequences. Clustering of ESTs
that are likely to be encoded by the same mRNA reduces
the redundancy in the EST database, improves the
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sequence quality and increases the sequence coverage for a
particular cluster.
By implementing a bioinformatic approach that in-
volves the clustering of more than 420,000 chicken ESTs,
we have identified eight novel AMPs in the chicken.
Clustering of these ESTs resulted in the generation of
34,819 chicken contigs and from this, 29,344 coding
sequences were predicted. Given estimates of the gene
number in human of 30,000 (Pennisi 2003), we expect to
have at least partial sequence information for most chicken
genes. TBLASTN searches (which searches protein
queries against a nucleotide database) of known AMPs
against the clustered EST contigs identified five contigs
with homology to the β-defensins, which we have named
Gal-4 to Gal-8. These searches also identified a novel
chicken cathelicidin. BLASTP searches (which searches
protein queries against a protein database translated in all
six reading frames) of proteins, predicted by ESTScan to
be encoded by these EST clusters, failed to identify any
other gallinacins or cathelicidins.
Due to their small size and poor sequence conservation,
searching for novel AMPs by conventional homology
search tools such as BLAST (Altschul et al. 1997) may
mean that significant hits are missed. However, the
presence of conserved motifs makes these peptides good
candidates for HMM profile searching. An HMM profile
is a probabilistic model of a protein family multiple-
sequence alignment, which uses position-specific scores to
indicate the likelihood of each amino acid occurring in
each position in the alignment (Eddy 1998). To search for
novel AMPs that could be missed by BLAST, we
constructed HMM profiles for a number of AMP families,
including α-defensins, gallinacins, cathelicidins and
hepcidins. The HMM profiles were then used to search
against the database of proteins predicted by ESTScan
from the EST clusters. This method identified two
additional gallinacins (Gal-9 and Gal-10). Furthermore,
this approach also led to the identification of a gallinacin-
like sequence that has unusual cysteine spacing. There is
evidence from other species that β-defensins with
alternative cysteine motifs are still active as AMPs
(Maxwell et al. 2003).
We have cloned and sequenced all the novel AMPs
identified in this study and submitted the sequences to
GenBank. The accession numbers and properties of the
predicted encoded proteins are summarised in Table 2. All
the sequences were in agreement with the EST predictions,
except for Gal-10, which had a single synonymous change
at base position 159 from C to T. We have examined the
expression of the known gallinacins (Gal-1–Gal-3), the
novel gallinacins (Gal-4–Gal-10), cathelicidin and LEAP-
2 in a panel of 21 different tissues from a healthy 3-week-
old chicken (Fig. 4). These tissues cover the digestive
system, the respiratory system, the genito-urinary system
and several other areas of the chicken anatomy.
The known gallinacins Gal-1 and Gal-2 are expressed
strongly in the bone marrow and the lung, as has been
previously shown (Zhao et al. 2001). However, we have
also shown strong expression of Gal-1 and Gal-2 in the
testis, moderate expression in the bursa and intestine and
low expression in the cloaca, gall bladder, brain and
pancreas. Gal-2 is also expressed at low levels in the
trachea, air sacs and spleen. The third known gallinacin,
Gal-3, was expressed in the tongue and bone marrow, as
has previously been shown (Zhao et al. 2001), however,
we found no Gal-3 expression in other tissues.
The novel gallinacins (Gal-4–Gal-10) exhibit variable
expression across most of the tissues examined, with
different gallinacins being expressed in different tissues.
The phylogenetically related Gal-4 and Gal-5 show a
similar pattern of expression, as does Gal-7, with all three
being highly expressed in the bone marrow and testis. Gal-
8 is also strongly expressed in the testis, and along with
Gal-6 shows very strong expression in the liver, gall
bladder and kidneys. Gal-9 is the only novel gallinacin to
be expressed in the tongue and also shows low expression
in the oesophagus, trachea, brain and bone marrow whilst
Gal-10 shows low expression in the large intestine,
kidneys and testis.
In addition to LEAP-2 being highly expressed in the
liver, similar levels of expression were found in the
Fig. 1 Neighbor-joined tree of the gallinacin family of AMPs.
Constructed using MEGA, version 2.1 (Poisson corrected model,
1,000 bootstrap replicates). Branches with less than 50% bootstrap
support have been collapsed. GAL1–10 Gallinacins (Gal-) 1–10,
GAL1A Gal-1α, THP turkey heterophil peptide, TBD turkey β-
defensin, BD07 MOUSE mouse β-defensin 7 (Q91V70)
Table 2 GenBank accession numbers and properties of novel
AMPs
Name Accession number Length (aa) Mr Net charge
Gal-4 AY534892 67 7.5 +8
Gal-5 AY534893 67 7.6 +7
Gal-6 AY534894 67 7.3 +3
Gal-7 AY534895 63 7.2 +8
Gal-8 AY534896 68 7.1 +2
Gal-9 AY534897 66 7.4 +4
Gal-10 AY534898 65 7.2 +2
LEAP-2 AY534899 76 8.8 +8
Cathelicidin AY534900 148 16.1 +2
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intestine, gall bladder and kidneys. These results are
consistent with studies of human LEAP-2, which is also
expressed in the liver, kidney and colon (Krause et al.
2003). Chicken cathelicidin is expressed across a wide
variety of tissues, but shows particularly high levels of
expression in the bursa, testis and bone marrow, and is the
only novel AMP to show expression in the gizzard.
Evolutionary analysis of the gallinacins
We have performed an evolutionary analysis of the
gallinacin family and have detected sites that are under
positive selection in these molecules. A neighbor-joining
phylogenetic tree was reconstructed from the amino acid
alignment (Fig. 1). This tree topology was used in the
subsequent analyses to detect adaptive evolution. To test
for variableωratios among phylogenetic lineages, the one-
ratio model (Goldman and Yang 1994)—which assumes
the sameω ratio for all lineages—was compared using the
LRT to the free-ratio model (Yang 1998), which assumes
an independent ω ratio for each branch. The free-ratio
model is not significantly better than the one-ratio model
(P>0.5) but does, however, predict variable ωvalues
among lineages, some of which are greater than 1 (Fig. 2).
Since the LRT did not reveal a significant difference, we
cannot conclude that there is evidence of positive selection
among the gallinacin lineages.
To test for positive selection at individual amino acid
sites, LRTs were carried out between model M0 and M3,
M1 and M2, and M7 and M8. All 3 models (M2, M3 and
M8) which allow for selection (Table 3) are significantly
favoured over the other models (P<0.001) in all cases
(Table 4). Gallinacins are encoded as prepropeptides that
are proteolytically cleaved to release the C-terminal AMP.
All of the sites predicted to be subject to positive selection
are located in the mature AMP and not in the prepropep-
tide region (Fig. 3a), suggesting functional significance.
The sites predicted to be subject to positive selection have
been displayed superimposed on the three-dimensional
structure of mouse β-defensin 7, a related molecule for
which a three-dimensional structure is available (Fig. 3b).
The sites under positive selection occur throughout the
molecule and no particular pattern or clustering of sites is
discernable.
Discussion
We have applied a bioinformatics approach that involves
the clustering of more than 420,000 ESTs to the identi-
fication of novel AMPs in the chicken. This approach has
Table 3 Evidence of adaptive evolution among sites in chicken gallinacins. ℓ Log-likelihood value for model, dN/dS Ratio of rates of
synonymous (dS) and non-synonymous (amino acid changing: dN) changes among the DNA sequences
Model ℓ dN/dS Positively Selected Sites
M0—one-ratio −2,662.94 0.5834
M1—neutral −2,581.48 0.8923
M2—selection −2,541.32 2.5815 25,29,30,33,34,39,42,45,47,49,52,54,55,57,58,63,65
M3—discrete −2,516.42 1.2094 21,23,24,25,26,27,28,29,30,32,33,34,35,39,42,45,46, 47,48,49,52,54,55,56,57,58,61,62,63,64,65
M7—β −2,531.96 0.6170
M8—βand ω −2,516.42 1.2987 25,29,30,42,45,52,57,63,65
Fig. 2 Phylogeny of gallinacins. Branch lengths were estimated by
maximum likelihood under the free-ratio model, which assumes an
independent ω value for each branch. Branches with no ω values
shown had values=∞. ω values >1 are shown in boldface
Table 4 Likelihood ratio test to detect adaptive evolution
Models 2Δℓ χ2value df P-value
M1 versus M2 2(−2581.48–2541.32) 80.32 2 <0.001
M0 versus M3 2(−2662.94–2541.32) 243.24 4 <0.001
M7 versus M8 2(−2531.96–2516.42) 31.08 2 <0.001
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Fig. 3 a Sites predicted to be under positive selection in the
gallinacins. Sites predicted to be under positive selection are
highlighted in the multiple-sequence alignment. Sites shown in red
are those sites predicted to be under positive selection (model M8).
Posterior probabilities for these sites are all greater than 0.95. Sites
shown in blue are the sites that 100% conserved across all
operational taxonomic units (OTUs). The mature AMP for Gal-1
is highlighted. b The structure of the mature mouse β-defensin 7
(PDB entry = 1E4T) was displayed using RasMol, version 2.7.2.1
(http://www.openrasmol.org/software/rasmol/). Sites shown in red
are those sites predicted to be under positive selection in the
gallinacins. Sites shown in blue are the sites that 100% conserved
across all OTUs
Fig. 4 Expression of Gal-1–
Gal-10, cathelicidin (Cath) and
liver-expressed antimicrobial
peptide 2 (LEAP-2) in a panel of
tissues from a healthy chicken. 1
tongue, 2 oesophagus, 3 pro-
ventriculus, 4 crop, 5 gizzard, 6
liver, 7 small intestine, 8
LARGE intestine, 9 cloaca, 10
bursa of Fabricius, 11 gall blad-
der, 12 trachea,13 lung, 14 air
sacs, 15 brain, 16 skin, 17
kidney, 18 spleen, 19 pancreas,
20 testis, 21 bone marrow
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identified nine novel AMPs, seven of which are
gallinacins, one a cathelicidin and one a LEAP-2 (Lynn
et al. 2003). We have shown the differential expression of
these genes in a panel of tissues from a single chicken and
have cloned and sequenced the mRNAs encoding these
novel AMPs. Identification of these AMPs in the chicken
will aid in the study of the innate immune response of the
chicken, economically an important species. Moreover,
these novel AMPs may be exploited for the development
of new therapeutic agents for economically significant
chicken diseases such as coccidiosis, which results in a
loss to the world poultry industry that is estimated at $700
million annually. These AMPs could be potentially
developed as natural alternatives to the artificial antibiotics
that are commonly fed to chickens and which are of
growing public concern.
In this study, we have also detected positive selection at
several amino acid sites located in the active antimicrobial
peptide region of the gallinacin family of antimicrobial
peptides. It is likely that as birds evolved to occupy new
niches, they were faced with new ranges of microbial
pathogens. Evolution of antimicrobial peptides with new
sensitivities capable of targeting novel infectious agents
would confer a selective advantage. There is experimental
evidence that gallinacin peptides are diverse in their
potency against different pathogens. For example, Gal-1
and Gal-1α are active against the yeast Candida albicans,
whereas the others tested so far do not show activity
(Evans et al. 1995; Harmon 1998). Our results indicate
that gallinacins have been subject to adaptive evolution to
increase the structural and functional diversity of this
protein family. This is an effective response in an arms
race against an increasing diversity of microbial patho-
gens.
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